These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34789668)

  • 21. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
    Flass T; Tong S; Frank DN; Wagner BD; Robertson CE; Kotter CV; Sokol RJ; Zemanick E; Accurso F; Hoffenberg EJ; Narkewicz MR
    PLoS One; 2015; 10(2):e0116967. PubMed ID: 25658710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a Cystic Fibrosis Enteropathy.
    Adriaanse MP; van der Sande LJ; van den Neucker AM; Menheere PP; Dompeling E; Buurman WA; Vreugdenhil AC
    PLoS One; 2015; 10(10):e0138062. PubMed ID: 26484665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas/CF.
    Van Biervliet S; Hauser B; Verhulst S; Stepman H; Delanghe J; Warzee JP; Pot B; Vandewiele T; Wilschanski M
    Clin Nutr ESPEN; 2018 Oct; 27():59-65. PubMed ID: 30144894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.
    López-Neyra A; Suárez L; Muñoz M; de Blas A; Ruiz de Valbuena M; Garriga M; Calvo J; Ribes C; Girón Moreno R; Máiz L; González D; Bousoño C; Manzanares J; Pastor Ó; Martínez-Botas J; Del Campo R; Cantón R; Roy G; Menacho M; Arroyo D; Zamora J; Soriano JB; Lamas A
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102186. PubMed ID: 33038833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scoring Abdominal Symptoms in People with Cystic Fibrosis.
    Tabori H; Barucha A; Zagoya C; Duckstein F; Dunay GA; Sadrieh P; Polte L; Mainz JG
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of timing of PERT on gastrointestinal symptoms in Danish children and adolescents with CF.
    Raun AMT; Brekke G; Mølgaard C; Jaudszus A; Mainz JG; Pressler T; Skov M
    Acta Paediatr; 2022 Feb; 111(2):432-439. PubMed ID: 34626004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis.
    Beaufils F; Mas E; Mittaine M; Addra M; Fayon M; Delhaes L; Clouzeau H; Galode F; Lamireau T; Bui S; Enaud R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33348735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders.
    Jeffery J; Lewis SJ; Ayling RM
    Inflamm Bowel Dis; 2009 Nov; 15(11):1630-4. PubMed ID: 19462434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
    Bruzzese E; Raia V; Gaudiello G; Polito G; Buccigrossi V; Formicola V; Guarino A
    Aliment Pharmacol Ther; 2004 Oct; 20(7):813-9. PubMed ID: 15379842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intestinal virome in children with cystic fibrosis differs from healthy controls.
    Coffey MJ; Low I; Stelzer-Braid S; Wemheuer B; Garg M; Thomas T; Jaffe A; Rawlinson WD; Ooi CY
    PLoS One; 2020; 15(5):e0233557. PubMed ID: 32442222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis.
    Moshiree B; Freeman AJ; Vu PT; Khan U; Ufret-Vincenty C; Heltshe SL; Goss CH; Schwarzenberg SJ; Freedman SD; Borowitz D; Sathe M;
    J Cyst Fibros; 2023 Mar; 22(2):266-274. PubMed ID: 36319569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity.
    Czub E; Nowak JK; Szaflarska-Poplawska A; Grzybowska-Chlebowczyk U; Landowski P; Moczko J; Adamczak D; Mankowski P; Banasiewicz T; Plawski A; Walkowiak J
    Acta Biochim Pol; 2014; 61(1):99-102. PubMed ID: 24649481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences.
    Eng A; Hayden HS; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Leung DH; Heltshe SL; Raftery D; Miller SI; Hoffman LR; Borenstein E
    BMC Microbiol; 2021 Sep; 21(1):247. PubMed ID: 34525965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update of faecal markers of inflammation in children with cystic fibrosis.
    Lee JM; Leach ST; Katz T; Day AS; Jaffe A; Ooi CY
    Mediators Inflamm; 2012; 2012():948367. PubMed ID: 22988347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary biomarkers in the context of gingival inflammation in children with cystic fibrosis.
    Yucel ZPK; Silbereisen A; Emingil G; Tokgoz Y; Kose T; Sorsa T; Tsilingaridis G; Bostanci N
    J Periodontol; 2020 Oct; 91(10):1339-1347. PubMed ID: 32100289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data.
    Więcek S; Chudek J; Woś H; Bożentowicz-Wikarek M; Kordys-Darmolinska B; Grzybowska-Chlebowczyk U
    Dis Markers; 2018; 2018():5940893. PubMed ID: 30116405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.
    McGarvey LP; Dunbar K; Martin SL; Brown V; Macmahon J; Ennis M; Elborn JS
    J Cyst Fibros; 2002 Dec; 1(4):269-75. PubMed ID: 15463826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.